ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0902

Neutrophils in Systemic Lupus Erythematosus Demonstrate Heterogeneity Based on Sex

William Ambler1, Gustaf Wigerblad1, Eduardo Patino-martinez1, Shuichiro Nakabo1, Norio Hanata1, Stephen Brooks2, Kan Jiang2, Carmelo Carmona-Rivera1 and Mariana Kaplan3, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skins Diseases, National Institutes of Health, Bethesda, MD, 2Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skins Diseases, National Institutes of Health, Bethesda, MD, 3Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH); Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

Meeting: ACR Convergence 2023

Keywords: gender, Gene Expression, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0899–0933) SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Sex differences in the immune system may contribute to o an increased incidence of autoimmunity in women and an increased susceptibility to infection and cancer in men. Human neutrophils, which have a putative role in systemic lupus erythematosus (SLE) disease initiation, propagation and tissue injury, display sexual dimorphism. This is characterized in healthy controls by female neutrophils exhibitingheightened type I-interferon (IFN) response and enhanced activation and NET formation compared to males, while men have less mature and activated neutrophils compared to women. SLE has a significant female bias (9:1 ratio). However, men with SLE often have very severe disease. It is not currently well understood if there are different immunological drivers in lupus between men and women and if sex differences in immune cells are present in SLE. There is a subset of neutrophils in SLE called low density granulocytes (LDGs) that have been reported to have important pathogenic roles in the disease but whether these cells exhibit sexual dimorphism is also not known. Understanding sex differences in immune cell subsets in SLE may improve understanding of disease heterogeneity and could provide insight for sex- specific treatment targets.

Methods: Age matched male and female patients with SLE were recruited from a comprehensive lupus clinic. Peripheral blood mononuclear cells (PBMC), LDGs and normal dense neutrophils (NDN) were purified and then subjected to cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) via the 10x platform. Downstream analysis was performed with Cell Ranger and the Seurat package in R. Functional assays were performed.

Results: Six patients with SLE (3 male and 3 female) have been analyzed thus far. The average age in years was 36.7 and 36.3 for males and females, respectively. Average SLEDAI was 6.7 and 4.7 male and female, respectively. All patients were on less than or equal to 15 mg of daily prednisone. There was significant heterogeneity between males and females in neutrophil analysis by CITE-Seq compared to other immune cells. Overall, females had an increased proportion of a type I IFN-stimulated gene (ISG)hi LDG cluster compared to males. Female LDGs had a higher IFN-I signature score. Female NDNs were similarly enriched in the ISGhi cluster and also had a higher IFN-I score compared to males. Male LDGs and NDNs were enriched in less mature neutrophil clusters. Other cell types did not display as much heterogeneity.

Conclusion: These preliminary results show sex differences in SLE by single cell transcriptomics with much of the heterogeneity arising from the neutrophils. More patients are currently being recruited to further understand neutrophil heterogeneity and functional implications in male and female lupus. This information may provide insight into SLE heterogeneity between sexes and could lead to stratified lupus treatments.


Disclosures: W. Ambler: None; G. Wigerblad: None; E. Patino-martinez: None; S. Nakabo: None; N. Hanata: None; S. Brooks: None; K. Jiang: None; C. Carmona-Rivera: None; M. Kaplan: AstraZeneca, 5, Bristol Myers Squibb, 5, Cytrill, 2, Neutrolis, 2.

To cite this abstract in AMA style:

Ambler W, Wigerblad G, Patino-martinez E, Nakabo S, Hanata N, Brooks S, Jiang K, Carmona-Rivera C, Kaplan M. Neutrophils in Systemic Lupus Erythematosus Demonstrate Heterogeneity Based on Sex [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/neutrophils-in-systemic-lupus-erythematosus-demonstrate-heterogeneity-based-on-sex/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophils-in-systemic-lupus-erythematosus-demonstrate-heterogeneity-based-on-sex/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology